Hamid R. Baniasadi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Hamid R. Baniasadi has a total of 36 co-authors. Here are the top co-authors by number of shared publications:
- Anthony J. Michael
Department of Biochemistry, UT Southwestern Medical Center, Dallas, Texas, USA
2 shared publications - Bin Li
Department of Biochemistry, University of Texas Southwestern Medical Center, Dallas, Texas TX 75390, U.S.A.
2 shared publications - Margaret A. Phillips
Department of Biochemistry, University of Texas Southwestern Medical Center, Dallas, Texas 75390, United States
2 shared publications - Ambadi Thody Sabareesan
National Centre for Biological Sciences, Tata Institute of Fundamental Research, Bengaluru 560065, India
1 shared publication - Andrew S. Lyon
Department of Biophysics, Howard Hughes Medical Institute, UT Southwestern Medical Center, Dallas, USA
1 shared publication - Arielle Click
Department of Immunology, University of Texas Southwestern Medical Center, Dallas, TX, USA
1 shared publication
Latest Publications
- Open Access
Global Metabolomic Analysis of Lytic KSHV Infection: Induced Host Nucleotide Metabolism is Required for Infectious Virus Production
Kaposi’s Sarcoma Herpes Virus (KSHV) is the etiological agent of Kaposi’s Sarcoma (KS) which is known to cause metabolic stress in infected host cells. KSHV reprograms host metabolic pathways for efficient viral replication and infectious virion production. Here, we report a time-course global metabolomics study conducted in the doxycycline-inducible iSLK.BAC16 cells to compare latent and lytic KSHV infection. Our data show that amino acid, central carbon, and nucleotide metabolic pathways are highly dysregulated upon reactivation to lytic replication. During lytic KSHV infection, pathway enrichment analysis shows that the top two most significantly impacted and dysregulated pathways are purine and pyrimidine metabolism. Further experiments have shown that nucleotide metabolism is required during lytic KSHV infection to produce maximal infectious virus. Treatment with the FDA-approved drug, methotrexate (MTX), a folate antagonist that inhibits cellular DHFR and decreases nucleotide metabolism by reducing tetrahydrofolate cofactors, significantly reduced KSHV late lytic viral gene expression upon reactivation compared to control. Additionally, titering cell-free supernatants from MTX-treated lytic KSHV-infected cells showed a significant reduction in infectious virion production. Furthermore, by adding folinic acid (FA), a downstream metabolite of the MTX-DHFR inhibition step, in the presence of MTX, late lytic gene expression and infectious virion production were significantly rescued. Furthermore, we observed a significant decrease in viral titer of murine herpesvirus 68 (MHV-68), a model virus to study gammaherpesvirus, after MTX treatment. Overall, our study demonstrates that metabolic inhibition during lytic gammaherpesvirus infection decreases productive infection and hence, serves as a potential therapeutic antiviral target.
Open AccessGlobal Metabolomic Analysis of Lytic KSHV Infection: Induced Host Nucleotide Metabolism is Required for Infectious Virus Production
Kaposi’s Sarcoma Herpes Virus (KSHV) is the etiological agent of Kaposi’s Sarcoma (KS) which is known to cause metabolic stress in infected host cells. KSHV reprograms host metabolic pathways for efficient viral replication and infectious virion production. Here, we report a time-course global metabolomics study conducted in the doxycycline-inducible iSLK.BAC16 cells to compare latent and lytic KSHV infection. Our data show that amino acid, central carbon, and nucleotide metabolic pathways are highly dysregulated upon reactivation to lytic replication. During lytic KSHV infection, pathway enrichment analysis shows that the top two most significantly impacted and dysregulated pathways are purine and pyrimidine metabolism. Further experiments have shown that nucleotide metabolism is required during lytic KSHV infection to produce maximal infectious virus. Treatment with the FDA-approved drug, methotrexate (MTX), a folate antagonist that inhibits cellular DHFR and decreases nucleotide metabolism by reducing tetrahydrofolate cofactors, significantly reduced KSHV late lytic viral gene expression upon reactivation compared to control. Additionally, titering cell-free supernatants from MTX-treated lytic KSHV-infected cells showed a significant reduction in infectious virion production. Furthermore, by adding folinic acid (FA), a downstream metabolite of the MTX-DHFR inhibition step, in the presence of MTX, late lytic gene expression and infectious virion production were significantly rescued. Furthermore, we observed a significant decrease in viral titer of murine herpesvirus 68 (MHV-68), a model virus to study gammaherpesvirus, after MTX treatment. Overall, our study demonstrates that metabolic inhibition during lytic gammaherpesvirus infection decreases productive infection and hence, serves as a potential therapeutic antiviral target.
- Top Cited Papers
- 15 January 2026
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 391 (6782) , eadq9006
Nucleotide metabolic rewiring enables NLRP3 inflammasome hyperactivation in obesity
Obesity is a major disease risk factor due to obesity-associated hyperinflammation. We found that obesity induced Nod-like receptor pyrin domain–containing 3 (NLRP3) inflammasome hyperactivation and excessive interleukin (IL)–1β production in macrophages by disrupting SAM and HD domain–containing protein 1 (SAMHD1), a deoxynucleoside triphosphate (dNTP) hydrolase crucial for nucleotide balance. This caused aberrant accumulation of dNTPs, which can be transported into mitochondria, and initiated mitochondrial DNA (mtDNA) neosynthesis, which increased the presence of oxidized mtDNA and triggered NLRP3 hyperactivation. Deletion of SAMHD1 promoted NLRP3 hyperactivation in cells isolated from zebrafish, mice, and humans. SAMHD1-deficient mice showed elevated circulating IL-1β, insulin resistance, and metabolic dysfunction–associated steatohepatitis. Blocking dNTP mitochondrial transport prevented NLRP3 hyperactivation in macrophages from obese patients and SAMHD1-deficient mice. Our study revealed that obesity by inhibiting SAMHD1 rewired macrophage nucleotide metabolism, thereby triggering NLRP3 inflammasome hyperactivation to drive disease progression.
- 15 January 2026
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 391 (6782) , eadq9006
Top Cited PapersNucleotide metabolic rewiring enables NLRP3 inflammasome hyperactivation in obesity
Obesity is a major disease risk factor due to obesity-associated hyperinflammation. We found that obesity induced Nod-like receptor pyrin domain–containing 3 (NLRP3) inflammasome hyperactivation and excessive interleukin (IL)–1β production in macrophages by disrupting SAM and HD domain–containing protein 1 (SAMHD1), a deoxynucleoside triphosphate (dNTP) hydrolase crucial for nucleotide balance. This caused aberrant accumulation of dNTPs, which can be transported into mitochondria, and initiated mitochondrial DNA (mtDNA) neosynthesis, which increased the presence of oxidized mtDNA and triggered NLRP3 hyperactivation. Deletion of SAMHD1 promoted NLRP3 hyperactivation in cells isolated from zebrafish, mice, and humans. SAMHD1-deficient mice showed elevated circulating IL-1β, insulin resistance, and metabolic dysfunction–associated steatohepatitis. Blocking dNTP mitochondrial transport prevented NLRP3 hyperactivation in macrophages from obese patients and SAMHD1-deficient mice. Our study revealed that obesity by inhibiting SAMHD1 rewired macrophage nucleotide metabolism, thereby triggering NLRP3 inflammasome hyperactivation to drive disease progression.
- Open Access
- 9 July 2025
- Published by Portland Press Ltd. in Biochemical Journal
- Vol. 482 (15)
The Pseudomonas aeruginosa Type VI secretion system toxin Tse8 evolved from a novel N-carbamoylputrescine amidohydrolase
The polyamine putrescine is synthesized primarily from L-arginine via agmatine in bacteria. There are currently three known routes from agmatine to putrescine, including direct conversion by agmatinase. The other two routes use agmatine deiminase to produce N-carbamoylputrescine from agmatine, then one of two nonhomologous enzymes, putrescine transcarbamylase or N-carbamoylputrescine amidohydrolase (NCPAH) convert N-carbamoylputrescine to putrescine. Here, we functionally identify enzymes from phylogenetically distant bacteria, the gamma-proteobacterium Shewanella oneidensis, and the actinomycetota species Microterricola gilva, that are novel alternative, nonhomologous, noncanonical NCPAHs that we term AguY, which have emerged by convergent evolution. Kinetic analysis indicates that the AguY enzymes are as efficient as the canonical NCPAH from Pseudomonas aeruginosa, in converting N-carbamoylputrescine to putrescine. Genomic evidence suggests that the AguY enzymes may participate in putrescine biosynthetic or agmatine catabolic pathways, and are occasionally encoded in genomes that also encode agmatinase. We show that the Type VI secretion system toxin Tse8 from Pseudomonas aeruginosa has evolved from AguY. It is formally possible that AguY evolved directly or indirectly from the ancient glutamine amidohydrolase GatA, a component of the transamidosome, an RNA/protein complex required for production of glutamine-charged tRNA. Our study provides a further example of the prevalence of convergent evolution and horizontal gene transfer in polyamine biosynthesis, suggesting pervasive selective pressure to evolve polyamine metabolism in bacteria.
- 9 July 2025
- Published by Portland Press Ltd. in Biochemical Journal
- Vol. 482 (15)
Open AccessThe Pseudomonas aeruginosa Type VI secretion system toxin Tse8 evolved from a novel N-carbamoylputrescine amidohydrolase
The polyamine putrescine is synthesized primarily from L-arginine via agmatine in bacteria. There are currently three known routes from agmatine to putrescine, including direct conversion by agmatinase. The other two routes use agmatine deiminase to produce N-carbamoylputrescine from agmatine, then one of two nonhomologous enzymes, putrescine transcarbamylase or N-carbamoylputrescine amidohydrolase (NCPAH) convert N-carbamoylputrescine to putrescine. Here, we functionally identify enzymes from phylogenetically distant bacteria, the gamma-proteobacterium Shewanella oneidensis, and the actinomycetota species Microterricola gilva, that are novel alternative, nonhomologous, noncanonical NCPAHs that we term AguY, which have emerged by convergent evolution. Kinetic analysis indicates that the AguY enzymes are as efficient as the canonical NCPAH from Pseudomonas aeruginosa, in converting N-carbamoylputrescine to putrescine. Genomic evidence suggests that the AguY enzymes may participate in putrescine biosynthetic or agmatine catabolic pathways, and are occasionally encoded in genomes that also encode agmatinase. We show that the Type VI secretion system toxin Tse8 from Pseudomonas aeruginosa has evolved from AguY. It is formally possible that AguY evolved directly or indirectly from the ancient glutamine amidohydrolase GatA, a component of the transamidosome, an RNA/protein complex required for production of glutamine-charged tRNA. Our study provides a further example of the prevalence of convergent evolution and horizontal gene transfer in polyamine biosynthesis, suggesting pervasive selective pressure to evolve polyamine metabolism in bacteria.
- Open Access
- 21 February 2023
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 120 (9)
Functional polyamine metabolic enzymes and pathways encoded by the virosphere
Viruses produce more viruses by manipulating the metabolic and replication systems of their host cells. Many have acquired metabolic genes from ancestral hosts and use the encoded enzymes to subvert host metabolism. The polyamine spermidine is required for bacteriophage and eukaryotic virus replication, and herein, we have identified and functionally characterized diverse phage- and virus-encoded polyamine metabolic enzymes and pathways. These include pyridoxal 5′-phosphate (PLP)-dependent ornithine decarboxylase (ODC), pyruvoyl-dependent ODC and arginine decarboxylase (ADC), arginase, S -adenosylmethionine decarboxylase (AdoMetDC/ speD ), spermidine synthase, homospermidine synthase, spermidine N -acetyltransferase, and N -acetylspermidine amidohydrolase. We identified homologs of the spermidine-modified translation factor eIF5a encoded by giant viruses of the Imitervirales . Although AdoMetDC/ speD is prevalent among marine phages, some homologs have lost AdoMetDC activity and have evolved into pyruvoyl-dependent ADC or ODC. The pelagiphages that encode the pyruvoyl-dependent ADCs infect the abundant ocean bacterium Candidatus Pelagibacter ubique , which we have found encodes a PLP-dependent ODC homolog that has evolved into an ADC, indicating that infected cells would contain both PLP- and pyruvoyl-dependent ADCs. Complete or partial spermidine or homospermidine biosynthetic pathways are found encoded in the giant viruses of the Algavirales and Imitervirales , and in addition, some viruses of the Imitervirales can release spermidine from the inactive N -acetylspermidine. In contrast, diverse phages encode spermidine N -acetyltransferase that can sequester spermidine into its inactive N -acetyl form. Together, the virome-encoded enzymes and pathways for biosynthesis and release or biochemical sequestration of spermidine or its structural analog homospermidine consolidate and expand evidence supporting an important and global role of spermidine in virus biology.
- 21 February 2023
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 120 (9)
Open AccessFunctional polyamine metabolic enzymes and pathways encoded by the virosphere
Viruses produce more viruses by manipulating the metabolic and replication systems of their host cells. Many have acquired metabolic genes from ancestral hosts and use the encoded enzymes to subvert host metabolism. The polyamine spermidine is required for bacteriophage and eukaryotic virus replication, and herein, we have identified and functionally characterized diverse phage- and virus-encoded polyamine metabolic enzymes and pathways. These include pyridoxal 5′-phosphate (PLP)-dependent ornithine decarboxylase (ODC), pyruvoyl-dependent ODC and arginine decarboxylase (ADC), arginase, S -adenosylmethionine decarboxylase (AdoMetDC/ speD ), spermidine synthase, homospermidine synthase, spermidine N -acetyltransferase, and N -acetylspermidine amidohydrolase. We identified homologs of the spermidine-modified translation factor eIF5a encoded by giant viruses of the Imitervirales . Although AdoMetDC/ speD is prevalent among marine phages, some homologs have lost AdoMetDC activity and have evolved into pyruvoyl-dependent ADC or ODC. The pelagiphages that encode the pyruvoyl-dependent ADCs infect the abundant ocean bacterium Candidatus Pelagibacter ubique , which we have found encodes a PLP-dependent ODC homolog that has evolved into an ADC, indicating that infected cells would contain both PLP- and pyruvoyl-dependent ADCs. Complete or partial spermidine or homospermidine biosynthetic pathways are found encoded in the giant viruses of the Algavirales and Imitervirales , and in addition, some viruses of the Imitervirales can release spermidine from the inactive N -acetylspermidine. In contrast, diverse phages encode spermidine N -acetyltransferase that can sequester spermidine into its inactive N -acetyl form. Together, the virome-encoded enzymes and pathways for biosynthesis and release or biochemical sequestration of spermidine or its structural analog homospermidine consolidate and expand evidence supporting an important and global role of spermidine in virus biology.
- Open Access
Small Molecule Properties Define Partitioning into Biomolecular Condensates
Biomolecular condensates regulate cellular function by compartmentalizing molecules without a surrounding membrane 1,2 . Condensate functions are believed to arise from the specific exclusion or enrichment of molecules 3-5 . Thus, understanding the principles governing condensate composition is critical to characterizing condensate function. The molecular bases of macromolecular composition have been studied in detail for several condensates 6-9 , but partitioning of small molecules into condensates remains poorly understood. Using mass spectrometry with validation by fluorescence microscopy, we quantified partitioning of ∼1700 metabolites and FDA-approved drugs into four condensates composed of different DNA and/or protein scaffolds. We found that partitioning spanned from ∼100-fold exclusion to ∼10,000-fold enrichment. Strong correlations between the different condensates suggest an underlying physical similarity despite disparate macromolecular components. Strongly partitioning molecules generally did not bind condensate-forming proteins with high affinity under conditions where condensates do not form, suggesting only a minor role for stereospecific interactions in partitioning. We developed a machine learning model that accurately predicts partitioning using only physicochemical properties of the compounds. The strongest predictors of partitioning were features related to aqueous solubility and hydrophobicity. Small molecule partitioning was similar for condensates in aqueous buffer and in concentrated cell extracts, suggesting analogous behaviors in vivo. Together, the data and model suggest that small molecule partitioning is not generally based on high-affinity, stereospecific interactions with scaffolds, but rather on physical properties of the compounds, and their compatibility with an emergent hydrophobic environment within the condensate. Our results will aid design of chemical compounds that target biomolecular condensates and reveal unexpected physical and functional similarities of distinct condensates.
Open AccessSmall Molecule Properties Define Partitioning into Biomolecular Condensates
Biomolecular condensates regulate cellular function by compartmentalizing molecules without a surrounding membrane 1,2 . Condensate functions are believed to arise from the specific exclusion or enrichment of molecules 3-5 . Thus, understanding the principles governing condensate composition is critical to characterizing condensate function. The molecular bases of macromolecular composition have been studied in detail for several condensates 6-9 , but partitioning of small molecules into condensates remains poorly understood. Using mass spectrometry with validation by fluorescence microscopy, we quantified partitioning of ∼1700 metabolites and FDA-approved drugs into four condensates composed of different DNA and/or protein scaffolds. We found that partitioning spanned from ∼100-fold exclusion to ∼10,000-fold enrichment. Strong correlations between the different condensates suggest an underlying physical similarity despite disparate macromolecular components. Strongly partitioning molecules generally did not bind condensate-forming proteins with high affinity under conditions where condensates do not form, suggesting only a minor role for stereospecific interactions in partitioning. We developed a machine learning model that accurately predicts partitioning using only physicochemical properties of the compounds. The strongest predictors of partitioning were features related to aqueous solubility and hydrophobicity. Small molecule partitioning was similar for condensates in aqueous buffer and in concentrated cell extracts, suggesting analogous behaviors in vivo. Together, the data and model suggest that small molecule partitioning is not generally based on high-affinity, stereospecific interactions with scaffolds, but rather on physical properties of the compounds, and their compatibility with an emergent hydrophobic environment within the condensate. Our results will aid design of chemical compounds that target biomolecular condensates and reveal unexpected physical and functional similarities of distinct condensates.